Usana Health Sciences Inc (USNA): Next-Year EPS Estimate 30.66%
As of 2026-06-11, Usana Health Sciences Inc (USNA) has a next-year EPS growth estimate of 30.66%.
On 2026-05-06, analyst consensus for USNA's next-year EPS growth shifted from 42.05% to 30.66% — a negative change of 11.39 percentage points. The revised estimate has been sustained across 27 subsequent trading sessions. Current-year growth is projected at 9.84%.
Current Snapshot
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- EPS growth next year
- 30.66%
- EPS growth this year
- 9.84%
- EPS next quarter (est)
- $0.43
- Last price
- $19.87
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 30.66% | 9.84% | $0.43 | $19.87 |
| 2026-06-10 | 30.66% | 9.84% | $0.43 | $19.17 |
| 2026-06-09 | 30.66% | 9.84% | $0.43 | $19.01 |
| 2026-06-08 | 30.66% | 9.84% | $0.43 | $18.70 |
| 2026-06-07 | 30.66% | 9.84% | $0.43 | $18.03 |
| 2026-06-04 | 30.66% | 9.84% | $0.43 | $18.13 |
| 2026-06-03 | 30.66% | 9.84% | $0.43 | $17.46 |
| 2026-06-02 | 30.66% | 9.84% | $0.43 | $18.05 |
| 2026-06-01 | 30.66% | 9.84% | $0.43 | $18.33 |
| 2026-05-31 | 30.66% | 9.84% | $0.43 | $18.30 |
| 2026-05-28 | 30.66% | 9.84% | $0.43 | $18.84 |
| 2026-05-27 | 30.66% | 9.84% | $0.43 | $18.80 |
| 2026-05-26 | 30.66% | 9.84% | $0.43 | $18.26 |
| 2026-05-25 | 30.66% | 9.84% | $0.43 | $18.74 |
| 2026-05-24 | 30.66% | 9.84% | $0.43 | $18.74 |
| 2026-05-21 | 30.66% | 9.84% | $0.43 | $18.56 |
| 2026-05-20 | 30.66% | 9.84% | $0.43 | $18.14 |
| 2026-05-19 | 30.66% | 9.84% | $0.43 | $17.47 |
| 2026-05-18 | 30.66% | 9.84% | $0.43 | $18.04 |
| 2026-05-17 | 30.66% | 9.84% | $0.43 | $17.98 |
| 2026-05-14 | 30.66% | 9.84% | $0.43 | $17.96 |
| 2026-05-13 | 30.66% | 9.84% | $0.43 | $17.76 |
| 2026-05-12 | 30.66% | 9.84% | $0.43 | $17.36 |
| 2026-05-11 | 30.66% | 9.84% | $0.43 | $17.43 |
| 2026-05-10 | 30.66% | 9.84% | $0.43 | $18.96 |
| 2026-05-07 | 30.66% | 9.84% | $0.43 | $19.46 |
| 2026-05-06 | 30.66% | 9.84% | $0.43 | $20.01 |
| 2026-05-05 | 42.05% | 1.04% | $0.44 | $19.26 |
| 2026-05-04 | 42.05% | 1.04% | $0.44 | $18.56 |
| 2026-05-03 | 42.05% | 1.04% | $0.44 | $19.35 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Usana Health Sciences Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Usana Health Sciences Inc (USNA) has a next-year EPS growth estimate of 30.66%, based on analyst consensus.
When was the latest EPS estimate revision for USNA?▾
The most recent revision occurred on 2026-05-06, when analysts adjusted the next-year EPS growth estimate from 42.05% to 30.66%.
What sector and industry does Usana Health Sciences Inc belong to?▾
Usana Health Sciences Inc operates in the Consumer Defensive sector, specifically the Packaged Foods industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. USNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Usana Health Sciences Inc (USNA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports